Ester Martı́n-Aparicio

1.1k total citations
18 papers, 851 citations indexed

About

Ester Martı́n-Aparicio is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ester Martı́n-Aparicio has authored 18 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Ester Martı́n-Aparicio's work include Genetic Neurodegenerative Diseases (5 papers), HER2/EGFR in Cancer Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ester Martı́n-Aparicio is often cited by papers focused on Genetic Neurodegenerative Diseases (5 papers), HER2/EGFR in Cancer Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Ester Martı́n-Aparicio collaborates with scholars based in Spain, United States and Netherlands. Ester Martı́n-Aparicio's co-authors include José J. Lucas, Jesús Ávila, Félix Hernández, Ai Yamamoto, Miguel Díaz‐Hernández, Pilar Gómez‐Ramos, María A. Morán, Isidró Ferrer, José G. Castaño and René Hen and has published in prestigious journals such as Journal of Neuroscience, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Ester Martı́n-Aparicio

18 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Martı́n-Aparicio Spain 12 541 338 128 120 103 18 851
Joanna Fombonne France 17 575 1.1× 230 0.7× 109 0.9× 106 0.9× 50 0.5× 22 1.0k
Marilyn Tirard Germany 11 470 0.9× 230 0.7× 103 0.8× 74 0.6× 98 1.0× 19 805
Judith Purcell United States 8 730 1.3× 372 1.1× 169 1.3× 55 0.5× 84 0.8× 8 954
James P. Finn United States 11 601 1.1× 368 1.1× 87 0.7× 56 0.5× 101 1.0× 15 940
María A. Morán Spain 10 498 0.9× 309 0.9× 142 1.1× 53 0.4× 118 1.1× 11 691
Mathieu Marella United States 18 794 1.5× 147 0.4× 64 0.5× 57 0.5× 135 1.3× 35 1.1k
April M. Weissmiller United States 16 584 1.1× 174 0.5× 131 1.0× 49 0.4× 90 0.9× 30 926
J. H. Steinbach United States 11 605 1.1× 371 1.1× 129 1.0× 44 0.4× 99 1.0× 17 989
Fanny C.F. Ip Hong Kong 15 479 0.9× 337 1.0× 150 1.2× 64 0.5× 28 0.3× 17 804
Renee Emkey United States 20 994 1.8× 237 0.7× 182 1.4× 64 0.5× 40 0.4× 37 1.3k

Countries citing papers authored by Ester Martı́n-Aparicio

Since Specialization
Citations

This map shows the geographic impact of Ester Martı́n-Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Martı́n-Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Martı́n-Aparicio more than expected).

Fields of papers citing papers by Ester Martı́n-Aparicio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Martı́n-Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Martı́n-Aparicio. The network helps show where Ester Martı́n-Aparicio may publish in the future.

Co-authorship network of co-authors of Ester Martı́n-Aparicio

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Martı́n-Aparicio. A scholar is included among the top collaborators of Ester Martı́n-Aparicio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Martı́n-Aparicio. Ester Martı́n-Aparicio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Martı́n-Aparicio, Ester, Sandra Zazo, Javier Martínez‐Useros, et al.. (2021). The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models. Cancers. 13(11). 2778–2778. 3 indexed citations
2.
Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2020). Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer. Molecular Cancer Therapeutics. 19(8). 1696–1707. 24 indexed citations
3.
Gónzález-Alonso, Paula, Sandra Zazo, Ester Martı́n-Aparicio, et al.. (2020). The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer. Cancers. 12(5). 1108–1108. 21 indexed citations
4.
Gónzález-Alonso, Paula, Ion Cristóbal, Sandra Zazo, et al.. (2018). Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models. Current Medicinal Chemistry. 25(17). 1976–1998. 3 indexed citations
5.
Rincón, Raúl, Sandra Zazo, Cristina Chamizo, et al.. (2016). c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2780–2790. 12 indexed citations
6.
Zazo, Sandra, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, et al.. (2016). Generation, characterization, and maintenance of trastuzumab-resistant HER2+ breast cancer cell lines.. PubMed. 6(11). 2661–2678. 37 indexed citations
7.
Gónzález-Alonso, Paula, Cristina Chamizo, Víctor Moreno, et al.. (2015). Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma. International Journal of Molecular Sciences. 16(8). 19447–19457. 3 indexed citations
8.
Rosa, Angelo O., Manuella P. Kaster, Ricardo W. Binfaré, et al.. (2008). Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(6). 1549–1556. 112 indexed citations
9.
Medina, Miguel, Ester Martı́n-Aparicio, Ana María de Caso Fuertes, et al.. (2008). P2‐402: A novel, highly specific glycogen synthase kinase‐3 inhibitor of marine origin. Alzheimer s & Dementia. 4(4S_Part_15). 1 indexed citations
10.
Hamann, Mark T., D. A. Alonso, Ester Martı́n-Aparicio, et al.. (2007). Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure–Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer’s Disease. Journal of Natural Products. 70(9). 1397–1405. 115 indexed citations
11.
Díaz‐Hernández, Miguel, Ester Martı́n-Aparicio, Jesús Ávila, Félix Hernández, & José J. Lucas. (2004). Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtin. Neurotoxicity Research. 6(6). 463–468. 36 indexed citations
12.
Martı́n-Aparicio, Ester, et al.. (2004). P4-428 TDZDS: GSK3β inhibitors as therapeutic agents for Alzheimer's disease and other tauopathies. Neurobiology of Aging. 25. S596–S596. 3 indexed citations
13.
Moreno-Flores, María Teresa, Ester Martı́n-Aparicio, María Jesús Martín‐Bermejo, et al.. (2003). Semaphorin 3C preserves survival and induces neuritogenesis of cerebellar granule neurons in culture. Journal of Neurochemistry. 87(4). 879–890. 34 indexed citations
14.
Díaz‐Hernández, Miguel, Félix Hernández, Ester Martı́n-Aparicio, et al.. (2003). Neuronal Induction of the Immunoproteasome in Huntington's Disease. Journal of Neuroscience. 23(37). 11653–11661. 209 indexed citations
15.
Martı́n-Aparicio, Ester, Jesús Ávila, & José J. Lucas. (2002). Nuclear localization of N‐terminal mutant huntingtin is cell cycle dependent. European Journal of Neuroscience. 16(2). 355–359. 23 indexed citations
16.
Lastres‐Becker, Isabel, Fernando Berrendero, José J. Lucas, et al.. (2002). Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington’s disease. Brain Research. 929(2). 236–242. 82 indexed citations
17.
Moreno-Flores, María Teresa, et al.. (2001). Fibronectin modulation by Aβ amyloid peptide (25–35) in cultured astrocytes of newborn rat cortex. Neuroscience Letters. 314(1-2). 87–91. 7 indexed citations
18.
Martı́n-Aparicio, Ester, Ai Yamamoto, Félix Hernández, et al.. (2001). Proteasomal-Dependent Aggregate Reversal and Absence of Cell Death in a Conditional Mouse Model of Huntington's Disease. Journal of Neuroscience. 21(22). 8772–8781. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Fombonne Breakdown of academic impact, for papers by Marilyn Tirard Breakdown of academic impact, for papers by Judith Purcell Breakdown of academic impact, for papers by James P. Finn Breakdown of academic impact, for papers by María A. Morán Breakdown of academic impact, for papers by Mathieu Marella Breakdown of academic impact, for papers by April M. Weissmiller Breakdown of academic impact, for papers by J. H. Steinbach Breakdown of academic impact, for papers by Fanny C.F. Ip Breakdown of academic impact, for papers by Renee Emkey
Rankless by CCL
2026